ESSA Pharma receives final approval to start trading on Toronto Stock Exchange

NewsGuard 100/100 Score
Jul 28 2015

ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX) is pleased to announce that it has received final approval for its common shares to be listed and commence trading on the Toronto Stock Exchange (the "TSX").

The Company's common shares will commence trading at the opening of trading on Tuesday, July 28, 2015 under the trading symbol 'EPI'. Concurrently, ESSA's common shares will be delisted from the TSX Venture Exchange.

Source:

ESSA Pharma Inc

Posted in: Business / Finance

Tags: , , , ,

Comments (0)

Suggested Reading

Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery
Study unveils novel bladder cancer diagnostic model based on key mitochondrial genes
Study links air pollution to increased colorectal cancer risk through DNA changes
New trials show promise for immune checkpoint blockers in early-stage lung cancer
Breast cancer survivors at higher risk of developing second cancers
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases
MONET: New AI tool enhances medical imaging with deep learning and text analysis

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New sustainable diagnostic approach offers precision cancer testing with minimal environmental impact